DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 10Dr. Reddy's Laboratories
02 2Breckenridge Pharmaceutical
03 2NanoAlvand
04 2medac
05 15Accord healthcare
06 2Accure Labs
07 2Actavis Inc
08 2Adcock Ingram
09 4Alphapharm PTY Ltd
10 1Altan Pharma
11 3Apotex Inc
12 6Astellas Pharma
13 2Auro Pharma Inc
14 2Aurobindo Pharma Limited
15 2Aurogen South Africa (Pty) Ltd
16 1Azurity Pharma
17 2Baxter Healthcare Corporation
18 2Biem Ilac San. ve Tic. A.S
19 5CEPHALON INC
20 2Capstone Development Services
21 2Chemi SpA
22 2CinnaGen
23 2Clinigen Group
24 2Cps Cito Pharma Services Gmbh
25 1Dr Reddy's Laboratories (Pty) Ltd
26 2EG SpA
27 1ELC Group
28 4EUGIA PHARMA (AUSTRALIA) PTY LTD
29 1EUGIA PHARMA INC.
30 2Eagle Pharmaceuticals
31 2Eriochem S.A.
32 1Eugia Pharma
33 2Fresenius Kabi AB Brunna
34 2Fresenius Kabi Oncology Limited
35 1Fresenius Kabi USA
36 1GetWell Pharmaceutical
37 3Glenmark Pharmaceuticals
38 2HOSPIRA INC
39 2Hetero Drugs
40 1Hikma Pharmaceuticals
41 3Hospira, Inc.
42 2INNOPHARMA LICENSING
43 1Intas Pharmaceuticals
44 1Jodas Expoim Pvt. Ltd
45 4Juno Pharmaceuticals Pty Ltd
46 1Karo Pharma
47 4Kiara Health
48 2MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH
49 2Meitheal Pharmaceuticals
50 2Nang Kuang Pharmaceutical Co. Ltd.
51 2Naprod Life Sciences
52 1Natco Pharma
53 2Natco Pharma (Canada) Inc
54 1ORIFARM GROUP AS
55 2PHARMOBEDIENT
56 1Panacea Biotec Limited
57 1Pfizer Inc
58 1SEACROSS PHARMACEUTICALS
59 1Sakar Healthcare
60 7Sandoz B2B
61 2Swan Pond Investments Limited
62 2Teva Pharmaceutical Industries
63 2TherDose Pharma
64 1Tillomed Laboratories Ltd
65 2Vama Lifecare
66 4Viatris
67 1Vinkem Labs Ltd
68 1XYZ Pharma
69 1pharma&
Reset all filters
01 4Bendamustina 100Mg 5 Units Parenteral Use
02 1Bendamustina 25Mg 20 Joined The Parenteral Use
03 4Bendamustina 25Mg 5 Units Parenteral Use
04 2Concentrate For Infusion Solution
05 2Concentrate For Solution For Infusion
06 1FREEZE-DRIED POWDER
07 1INF
08 1INJECTABLE; INJECTION
09 4INJECTION
10 1Infusion
11 2Injectable
12 14Injection
13 1Liquid Injection
14 1Lyo.Inj
15 1Lyophilised Injection
16 1Lyophilized Injection
17 2Lyophilized Powder for Solution for Infusion
18 12POI
19 11POWDER FOR SOLUTION
20 18POWDER;INTRAVENOUS
21 8POWDER;IV (INFUSION)
22 1Powder For Concentrate For Infusion Solution
23 29Powder For Concentrate For Solution For Infusion
24 8Powder to concentrate to the infusion fluid, resolution
25 1SOLUTION
26 12SOLUTION;INTRAVENOUS
27 1SOLUTION;IV (INFUSION)
28 2Vial
29 16Blank
Reset all filters
01 7Allowed
02 5Approved
03 8Authorized
04 7Cancelled
05 14DISCN
06 6Deregistered
07 20Generic
08 1Lead Market Dossiers- Approved in EU
09 4Lead Market Dossiers- Filed
10 2Lead Market Dossiers- Tentative\nApproved in US
11 12Prescription
12 15RX
13 1Suspensed
14 60Blank
Reset all filters
01 1BELRAPZO
02 4BENDAMUSTINE EUGIA
03 32BENDAMUSTINE HYDROCHLORIDE
04 7BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
05 1BENDAWEL
06 1BENDEKA
07 1BENVYON
08 1Baximo 100 mg
09 1Baximo 25 mg
10 2Beastin
11 1Bendahet 100
12 1Bendahet 25
13 3Bendamustin Actavis
14 6Bendamustina
15 2Bendamustina Accord
16 1Bendamustina Altan
17 1Bendamustina Aurovitas
18 1Bendamustina Baxter
19 1Bendamustina Glenmark
20 1Bendamustina Hikma
21 1Bendamustina Intas
22 1Bendamustina Medac
23 1Bendamustina Mylan
24 1Bendamustina Spi
25 1Bendamustina Swanpond Investments
26 1Bendamustina Tillomed
27 1Bendamustine 180mg/4ml DRL
28 6Bendamustine Accord
29 1Bendamustine Accord liquid
30 1Bendamustine Elc
31 3Bendamustine Fresenius Kabi
32 4Bendamustine Juno
33 1Bendamustine Medac
34 7Bendamustine Sandoz
35 4Bendamustine Viatris
36 1Bendamyl
37 4Bendanit
38 2ERIOTIB
39 1Equiben 100
40 1Equiben 25
41 1Kabi Bandamustine
42 6Levact
43 2Mustinal
44 2NAT-BENDAMUSTINE
45 1Omuben 100mg
46 1Omuben 25 mg
47 2Ribomustin
48 2Ribomustin 100 mg
49 2Ribomustin 25 mg
50 2Ribovact
51 2THERMUSTINE
52 7TREANDA
53 1VIVIMUSTA
54 19Blank
Reset all filters
01 2Argentina
02 16Australia
03 12Canada
04 21India
05 4Iran
06 9Italy
07 8Norway
08 13South Africa
09 16Spain
10 11Sweden
11 7Switzerland
12 2Turkey
13 40USA
14 1United Kingdom
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date : 2022-12-07
Application Number : 205376
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date : 2023-02-14
Application Number : 205447
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Iran
Brand Name : Bendanit
Dosage Form : Vial
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Bendamustine Medac
Dosage Form : Powder For Concentrate For Solution For Infusion
Dosage Strength : 2.5mg/ml
Packaging :
Approval Date : 10/03/2016
Application Number : 20150730000024
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2022-12-07
Application Number : 205376
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 100MG/4ML (25MG/ML)
Packaging :
Approval Date : 2025-07-03
Application Number : 219014
Regulatory Info : DISCN
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 45MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 25MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in EU
Registration Country : India
Brand Name :
Dosage Form : Infusion
Dosage Strength : 180MG/4ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in EU
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2023-02-14
Application Number : 205447
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Iran
Brand Name : Bendanit
Dosage Form : Vial
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.
Regulatory Info : Cancelled
Registration Country : Spain
Brand Name : Bendamustina Medac
Dosage Form : Powder For Concentrate For Solution For Infusion
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2019-11-04
Application Number : 80255
Regulatory Info : Cancelled
Registration Country : Spain
Regulatory Info : RX
Registration Country : USA
Brand Name : TREANDA
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2008-03-20
Application Number : 22249
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TREANDA
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date : 2009-05-01
Application Number : 22249
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TREANDA
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 45MG/0.5ML (90MG/ML)
Packaging :
Approval Date : 2013-09-13
Application Number : 22249
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TREANDA
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 180MG/2ML (90MG/ML)
Packaging :
Approval Date : 2013-09-13
Application Number : 22249
Regulatory Info : DISCN
Registration Country : USA